Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 17, 2024
Accuracy of 14 intraocular lens power calculation formulas in extremely long eyesXinxin Li, Chunyuan Song, Yong Wang, et al.
International Immunopharmacology|July 12, 2022
Igf2bp2 knockdown improves CCl4-induced liver fibrosis and TGF-β-activated mouse hepatic stellate cells by regulating Tgfbr1Zhenyu Xu, Bo He, Yongfang Jiang, et al.
Chemosphere|June 19, 2022
Tracing the sources of phosphorus in lake at watershed scale using phosphate oxygen isotope (δ18OP)Hezhong Yuan, Haixiang Wang, Azhong Dong, et al.
SLAS Technology|December 6, 2025
Deciphering OCT4A-dose-dependent transcriptional profiles associated with tumorigenic potential in somatic cancer cellsMin Tang, Rui Liang, Zhenyu Wu, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 19, 2019
Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4Chao Ye, Xiaoqian Zhang, Xinyu Chen, et al.
Scientific Reports|April 7, 2017
Dual inhibiting OCT4 and AKT potently suppresses the propagation of human cancer cellsWenxin Li, Yanwen Zhou, Xiaoqian Zhang, et al.
Scientific Reports|May 14, 2021
LSD1-mediated demethylation of OCT4 safeguards pluripotent stem cells by maintaining the transcription of PORE-motif-containing genesSongsong Dan, Yuelin Song, Xiaotao Duan, et al.
Cell Death & Disease|May 24, 2018
Endogenous authentic OCT4A proteins directly regulate FOS/AP-1 transcription in somatic cancer cellsYanwen Zhou, Xinyu Chen, Bo Kang, et al.
Nature Communications|June 11, 2015
Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cellsJie Cheng, Wenxin Li, Bo Kang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 8, 2020
SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trialFang Zheng, Yanwen Zhou, Zhiguo Zhou, et al.
Pageof 4